Intra-Tumor AvidinOX Allows Efficacy of Low Dose Systemic Biotinylated Cetuximab in a Model of Head and Neck Cancer

Oncotarget - United States
doi 10.18632/oncotarget.6089
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Platinum-Based Chemotherapy Plus Cetuximab in Head and Neck Cancer

New England Journal of Medicine
Medicine
2008English

Cetuximab in Locally Advanced Head-And-Neck Cancer: Defining the Population

Current Oncology
Oncology
2010English

Evaluation of Chemoradiotherapy of Low Dose Carboplatin (CBDCA) for Head and Neck Cancer.

Practica Otologica
Otorhinolaryngology
1995English

Intra-Tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data From the Cancer Genome Atlas

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2015English

Late Systemic Symptoms in Head and Neck Cancer Survivors

Supportive Care in Cancer
Oncology
2018English

Chronologic Aging Decreases Tumor Angiogenesis and Metastasis in a Mouse Model of Head and Neck Cancer

International Journal of Oncology
Cancer ResearchOncology
2010English

Correction: Intra-Tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data From the Cancer Genome Atlas

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2015English

Evaluation of Weekly Paclitaxel, Carboplatin, and Cetuximab in Head and Neck Cancer Patients With Incurable Disease

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy